Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN493368 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B) (pThr181) antibody
- Antibody type
- Polyclonal
- Antigen
- Phopshorylated synthetic peptide (KLH conjugated) corresponding to aa 178-198. AA Sequence: SVET(p)PKKPGLC
- Reactivity
- Human, Mouse, Rat, Chicken/Avian, Simian
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 0.1 mg
- Concentration
- 0.5-0.75 mg/ml (lot. specific)
- Storage
- Store the antibody undiluted (in aliquots) at -20°C. Avoid repeated freezing and thawing. Shelf life: one year from despatch.
Submitted references Localized orbital theory and ammonia triborane.
Reciprocal control of Forkhead box O 3a and c-Myc via the phosphatidylinositol 3-kinase pathway coordinately regulates p27Kip1 levels.
Role of the CDK inhibitor p27 (Kip1) in mammary development and carcinogenesis: insights from knockout mice.
A novel mammalian cell-based approach for the discovery of anticancer drugs with reduced cytotoxicity on non-dividing cells.
Cell cycle regulatory protein p27KIP1 is a substrate and interacts with the protein kinase CK2.
MAP kinase-dependent degradation of p27Kip1 by calpains in choroidal melanoma cells. Requirement of p27Kip1 nuclear export.
Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization.
Subotnik JE, Sodt A, Head-Gordon M
Physical chemistry chemical physics : PCCP 2007 Nov 7;9(41):5522-30
Physical chemistry chemical physics : PCCP 2007 Nov 7;9(41):5522-30
Reciprocal control of Forkhead box O 3a and c-Myc via the phosphatidylinositol 3-kinase pathway coordinately regulates p27Kip1 levels.
Chandramohan V, Jeay S, Pianetti S, Sonenshein GE
Journal of immunology (Baltimore, Md. : 1950) 2004 May 1;172(9):5522-7
Journal of immunology (Baltimore, Md. : 1950) 2004 May 1;172(9):5522-7
Role of the CDK inhibitor p27 (Kip1) in mammary development and carcinogenesis: insights from knockout mice.
Musgrove EA, Davison EA, Ormandy CJ
Journal of mammary gland biology and neoplasia 2004 Jan;9(1):55-66
Journal of mammary gland biology and neoplasia 2004 Jan;9(1):55-66
A novel mammalian cell-based approach for the discovery of anticancer drugs with reduced cytotoxicity on non-dividing cells.
Gonzalez-Nicolini V, Fux C, Fussenegger M
Investigational new drugs 2004 Aug;22(3):253-62
Investigational new drugs 2004 Aug;22(3):253-62
Cell cycle regulatory protein p27KIP1 is a substrate and interacts with the protein kinase CK2.
Tapia JC, Bolanos-Garcia VM, Sayed M, Allende CC, Allende JE
Journal of cellular biochemistry 2004 Apr 1;91(5):865-79
Journal of cellular biochemistry 2004 Apr 1;91(5):865-79
MAP kinase-dependent degradation of p27Kip1 by calpains in choroidal melanoma cells. Requirement of p27Kip1 nuclear export.
Delmas C, Aragou N, Poussard S, Cottin P, Darbon JM, Manenti S
The Journal of biological chemistry 2003 Apr 4;278(14):12443-51
The Journal of biological chemistry 2003 Apr 4;278(14):12443-51
Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization.
Fujita N, Sato S, Katayama K, Tsuruo T
The Journal of biological chemistry 2002 Aug 9;277(32):28706-13
The Journal of biological chemistry 2002 Aug 9;277(32):28706-13
No comments: Submit comment
No validations: Submit validation data